A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/415 (2006.01) A61K 31/216 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2642850
An alpha2 adrenoreceptor agonist eg. clonidine, brimonidine, monoxidine, lofexidine is useful for the treatment of siaiorrhoea, administered by the paraungual, sublingual or buccal route. The patient to be treated is also given an anti-muscarinic agent eg. oxybutynin, glycopyrrolate, ipratropium.
Un agoniste du récepteur adrénergique alpha 2 tel que la clonidine, la brimonidine, la monoxidine, la lofexidine est utile pour le traitement de la sialorrhée lorsqu'il est administré par voie paralinguale, sublinguale ou buccale. Le patient à traiter reçoit également un agent anti-muscarinique tel que l'oxybutynine, le glycopyrrolate, l'ipratropium.
Goldsmith Paul
Roach Alan Geoffrey
Gowling Lafleur Henderson Llp
Orient Pharma (samoa) Co. Ltd.
Summit Corporation Plc
LandOfFree
Combination of alpha-2 receptor agonist (clonidin) and an... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of alpha-2 receptor agonist (clonidin) and an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of alpha-2 receptor agonist (clonidin) and an... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2030830